Prothrombin Time/INR (PT)

The PT/INR test measures how quickly your blood clots using one of the main clotting pathways, and it is commonly used to monitor blood-thinning medications like warfarin or to check how well your liver is working. A result within the normal range means your clotting factors are functioning properly, while a high result may mean your blood is clotting more slowly than expected.

When elevated: An elevated PT/INR in a non-anticoagulated patient suggests deficiency or dysfunction of one or more extrinsic/common pathway factors, which may reflect liver disease, vitamin K deficiency, disseminated intravascular coagulation (DIC), or a specific factor inhibitor. Markedly elevated INR (>1.5 in surgical patients, >2.0 in general) is associated with increased risk of spontaneous or procedural bleeding and may require intervention before invasive procedures. In the context of warfarin therapy, supratherapeutic INR substantially increases hemorrhagic risk, particularly for intracranial bleeding. When low: A PT/INR below the lower reference limit (INR <0.8) is uncommon and not reliably associated with clinically significant hypercoagulability in most clinical contexts, as the PT does not measure anticoagulant pathways. Low INR may occasionally be observed with elevated factor VII or VIII levels, early DIC (consumptive phase), or in patients with high dietary vitamin K intake. Clinical significance of a low INR in a non-anticoagulated patient is generally limited, and isolated low INR should not be used to diagnose a thrombophilic state without additional workup.

PT/INR is not a routine performance or training marker for healthy athletes. However, it becomes relevant if you're taking anticoagulants (e.g., post-injury or for a clotting disorder), have liver stress from extreme training or supplement use, or need pre-surgery clearance. Monitoring ensures your clotting system remains stable during intense exercise.